- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05840900
Mindfulness, Optimism, and Resilience for Perinatal Health and Equity Study (MORPHE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized clinical trial of nulliparous women with low dispositional optimism in early pregnancy seeks to determine whether use of a pregnancy-oriented digital mindfulness application will be feasible and acceptable and show preliminary evidence of efficacy in improving dispositional optimism, reducing adverse perinatal outcomes and improving postpartum post-traumatic stress symptoms.
This pilot will include 100 women recruited from the obstetrical service at Women and Infants Hospital of Rhode Island. Women will be included if they are nulliparous, have a singleton pregnancy at <20 weeks gestational age, speak English and have low dispositional optimism (a score of ≤14 on the validated, Revised Life Orientation Test). Eligible participants will be randomized to either using the digital app Expectful or standard pregnancy care.
Women will be randomized with equal probability to the intervention group using block randomization stratified by race/ethnicity (Hispanic, non-Hispanic White/Other or non-Hispanic Black).
Women in the mindfulness training arm will complete 8 weeks of daily mindfulness training exercises using Expectful. Women in the standard care group will receive standard pregnancy and postpartum care. Pregnancy and labor management will be at the discretion of each participant's obstetric provider.
Participants in both groups will be asked to complete 4 questionnaires: one at enrollment, a post-intervention one at 8 weeks, at the time of delivery and at 6-8 weeks postpartum. Half of the participants in each arm (total n=50), will be asked to complete a qualitative, semi-structured interview on the role of optimism and other resilience factors in pregnancy.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nina K Ayala, MD, MSCR
- Phone Number: 43435 401-274-1100
- Email: nayala@carene.org
Study Contact Backup
- Name: Emily S Miller, MD, MPH
- Phone Number: 47452 401-274-1100
- Email: emmiller@carene.org
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02905
- Recruiting
- Obstetrics and Gynecology Care Center
-
Contact:
- Nina K. Ayala, MD
-
Providence, Rhode Island, United States, 02905
- Recruiting
- Prenatal Diagnosis Center
-
Contact:
- Nina K. Ayala, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Able to provide informed consent
- English speaking
- Nulliparous (no prior delivery at or greater than 20w0d gestation)
- Pregnant with singleton fetus
- <20w0d gestation
- Low dispositional optimism (score </= 14 on the Revised Life Orientation Test)
- Owns a smart phone
Exclusion Criteria:
- Plan to deliver at another institution
- Ongoing (≥1/week) mind-body practice including mindfulness training, meditation or yoga
- Pre-gestational hypertensive disorder
- Pre-gestational diabetes mellitus
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: App-based mindfulness training
App-based daily mindfulness training Standard prenatal and pregnancy care
|
Once daily, 5-10 minute mindfulness exercises for 8 week intervention period using the existing perinatal mindfulness application Expectful
|
|
No Intervention: Usual Care
Standard prenatal and pregnancy care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of participants completing the assigned mindfulness exercises
Time Frame: 8-week intervention period
|
The intervention will be considered feasible if ≥75% participants complete >50% of the assigned daily mindfulness exercises over the 8-week intervention period
|
8-week intervention period
|
|
Intervention acceptability
Time Frame: After 8 week intervention period, approximately 16-28 weeks gestation.
|
The intervention will be considered acceptable if ≥75% report "satisfied" or "very satisfied" on a post-intervention consumer satisfaction survey with a 5-point Likert scale from very unsatisfied to very satisfied.
|
After 8 week intervention period, approximately 16-28 weeks gestation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dispositional optimism
Time Frame: Study enrollment and 6-12 weeks postpartum
|
Change in dispositional optimism score (on validated Revised Life Orientation Test, scale range 0-24, higher scores indicate higher optimism) between enrollment and postpartum assessments
|
Study enrollment and 6-12 weeks postpartum
|
|
Cesarean delivery
Time Frame: Delivery
|
Binary yes/no
|
Delivery
|
|
Hypertensive disorder of pregnancy
Time Frame: 6-12 weeks postpartum
|
Binary yes/no; includes gestational hypertension, pre-eclampsia with or without severe features, HELLP syndrome or eclampsia
|
6-12 weeks postpartum
|
|
Gestational diabetes mellitus
Time Frame: Delivery
|
Binary yes/no
|
Delivery
|
|
Preterm birth
Time Frame: Delivery
|
Binary yes/no; Delivery between 20w0d and 36w6d gestation
|
Delivery
|
|
Traumatic birth
Time Frame: Delivery
|
Binary yes/no; Self-reported experience of birth as traumatic given concern for life or well-being of self or infant
|
Delivery
|
|
Postpartum post-traumatic stress symptoms
Time Frame: 6-12 weeks postpartum
|
Continuous scale score using the PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders (PCL-5, scale range 0-80, higher scores indicate worse post-traumatic stress symptoms)
|
6-12 weeks postpartum
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1983168
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postpartum Psychiatric Disorders
-
Ömer USLUCompletedPsychoeducation | Psychiatric Nursing | Forgiveness | Puerperal Depression | Depression DisorderTurkey (Türkiye)
-
Stéphane MorandiUniversity of LausanneNot yet recruitingPsychiatric Disorder | Involuntary Psychiatric HospitalizationSwitzerland
-
Uppsala UniversityTerminatedPsychosis | Psychiatric Disorder | Psychiatric Hospitalization | Compulsory Psychiatric Care Act | Acceptance & Commitment TherapySweden
-
University of Lausanne HospitalsCompletedPsychiatric Disorder | Involuntary Psychiatric HospitalizationSwitzerland
-
The Miriam HospitalCompletedTobacco Smoking | Psychiatric Disorder | Psychiatric HospitalizationUnited States
-
University of South FloridaTemple University; National Institute on Disability, Independent Living, and... and other collaboratorsRecruitingMental Illness | Behavior Disorders | Psychiatric Diagnosis | Psychiatric Disorders | Severe Mental Illness | Psychiatric Diseases | Psychiatric IllnessUnited States
-
Mental Health Services in the Capital Region, DenmarkUniversity of CopenhagenRecruitingMental Illness | Behavior Disorders | Psychiatric Disorder | Mental Disorder | Severe Mental Disorder | Psychiatric Illness | Diagnosis, Psychiatric | Psychiatric Disease | Diagnosis DualDenmark
-
Kuopio University HospitalUniversity of Eastern FinlandTerminatedPsychiatric DiseasesFinland
-
Roswell Park Cancer InstituteRecruitingPsychiatric DisorderUnited States
-
Stanford UniversityRecruiting
Clinical Trials on Digital Mindfulness Training
-
Hospital Universitario La PazInstituto de Investigación Hospital Universitario La PazRecruiting
-
Singapore Management UniversityNot yet recruitingDigital Mindfulness Intervention
-
Northwestern UniversityRecruitingTreatment Adherence and Compliance | Meditation | Mindfulness | Self-Compassion | Psychological Well-Being | Meditation Training | Physician Burnout | Program EngagementUnited States
-
Karl Landsteiner Institute for Lung Research and...Klinik Ottakring; University of Vienna; Klinik Floridsdorf; Therme Wien Med (Ambulant...CompletedChronic Obstructive Pulmonary Disease ExacerbationAustria
-
National Health Research Institutes, TaiwanCompletedBurnout, Professional | Stress, Psychological | Caregivers | Caregivers BurnoutTaiwan
-
University of California, San DiegoCompleted
-
Yale UniversityCompletedMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) | Mental Health Wellness 1 | War-Related TraumaJordan
-
McMaster UniversityNot yet recruiting
-
King's College LondonCompletedAdults With Overweight and ObesityUnited Kingdom